BioPharma Credit PLC Holding(s) in Company (8411B)
07 April 2017 - 12:45AM
UK Regulatory
TIDMBPCR
RNS Number : 8411B
BioPharma Credit PLC
06 April 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
-----------------------------------------------
1. Identity of the issuer or BioPharma Credit PLC
the underlying issuer
of existing shares to which
voting rights are
attached:
---------------------------------------------------------- -------------------------------
2. Reason for the notification (please tick the appropriate
box or boxes):
-------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
------------------------------------------------------------------------------------- ----
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
------------------------------------------------------------------------------------- ----
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
------------------------------------------------------------------------------------- ----
An event changing the breakdown of voting rights
------------------------------------------------------------------------------------- ----
Other (please Issue of New Shares Yes
specify):
--------------------------------------------------------- -------------------------- ----
3. Full name of person(s) Pablo Legorreta
subject to the
notification obligation:
---------------------------------------------------------- -------------------------------
4. Full name of shareholder(s) Pablo Legorreta
(if different from 3.): Benjamin Schliemann
---------------------------------------------------------- -------------------------------
5. Date of the transaction 27 March 2017, 30 March 2017
and date on
which the threshold is
crossed or
reached:
---------------------------------------------------------- -------------------------------
6. Date on which issuer 5 April 2017
notified:
---------------------------------------------------------- -------------------------------
7. Threshold(s) that is/are
crossed or
reached: 3%
---------------------------------------------------------- -------------------------------
8. Notified details:
----------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares
----------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------- -------------------------------- ---------------------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights
Shares Voting rights
Rights
------------- --------------- --------------- -------------- -------------------------- -------------------------
Direct Direct Indirect Direct Indirect
/ Indirect
------------- ----------- ----------- -------------- ------------- ----------- ------------ -----------
Below Below
ORD USD0.01 4% 4% 28,767,015 27,411,842 1,355,173 3.6% 0.2%
--------------- --------------- -------------- ------------- ----------- ------------ -----------
GB00BDGKMY29
------------- ----------- ----------- ------------ ----------- ----------- -------- ---------
B: Qualifying Financial Instruments
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument Period may be
acquired if
the
instrument
is
exercised/
converted.
----------------- ------------- ------------------------------- ---------------------------- ---------------------
N/A N/A N/A N/A N/A
----------------- ------------- ------------------------------- ---------------------------- ---------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights
instrument period refers to
--------------- ------------- ------------- ---------------- ---------------------------- -----------------------
N/A N/A N/A N/A N/A Nominal Delta
--------------- ------------- ------------- ---------------- ---------------------------- ------------ ---------
N/A N/A
------------- ----------- ----------- ------------ ----------- ----------- ------------ ---------
Total (A+B+C)
----------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------------------------------- -------------------------------------------------------------------
28,767,015 3.8%
------------------------------------------------- -------------------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
-------------------------------------------------------------------------------
Proxy Voting:
-------------------------------------------------------------------------------
10. Name of the proxy holder:
------------------------------------------------------------- ----------------
11. Number of voting rights proxy
holder will cease
to hold:
------------------------------------------------------------- ----------------
12. Date on which proxy holder will
cease to hold
voting rights:
------------------------------------------------------------- ----------------
13. Additional information:
------------------------------------------------------------- ----------------
14. Contact name: George Lloyd
------------------------------------------------------------- ----------------
15. Contact telephone number: +1-212-883-2275
------------------------------------------------------------- ----------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUNRSRBWASRAR
(END) Dow Jones Newswires
April 06, 2017 10:45 ET (14:45 GMT)
Biopharma Credit (LSE:BPCR)
Historical Stock Chart
From Apr 2024 to May 2024
Biopharma Credit (LSE:BPCR)
Historical Stock Chart
From May 2023 to May 2024